Get all your news in one place.
100's of premium titles.
One app.
Start reading
StockNews.com
StockNews.com
Business
Kritika Sarmah

3 Pharma Powerhouses for Long-Term Growth in 2024

The global pharma market is expanding with rising healthcare demand and precision medicine advances, fueled by a growing focus on health and longevity. Thus, investors could consider investing in robust pharma stocks Collegium Pharmaceutical, Inc. (COLL), AstraZeneca PLC (AZN), and Merck & Co., Inc. (MRK) in 2024, given their solid growth prospects.

Last year, global biopharma R&D funding rose to $72 billion, with 69 novel active substances launched globally, including 24 in the United States. Clinical development productivity surged to 17.4, the highest since 2018, driven by improved success rates and innovative trial methodologies.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.